An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.

R Rosso; M R Sertoli; P Queirolo; O Sanguineti; M C Barzacchi; G L Mariani; L Miglio; M Venturini; S Toma

doi:10.1093/oxfordjournals.annonc.a058261

An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.

Identifier:nobleid.org/w1/20260515/E115D030

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E115D030.svg?ark=w1%2F20260515%2FE115D030)](https://nobleid.org/work/w1/20260515/E115D030)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

An outpatient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies.

Identifier:nobleid.org/w1/20260515/E115D030

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E115D030.svg?ark=w1%2F20260515%2FE115D030)](https://nobleid.org/work/w1/20260515/E115D030)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work